NCT06357663

Brief Summary

Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Telomere Length in Peripheral Blood Leukocytes A Follow-up Pilot Study The goal of this Pilot clinical trial is to learn if a Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice works to increase Telomere Length in Peripheral Blood Leukocytes in adults. The main questions it aims to answer are:

  • Does A Subtle energy transmission and Tao Calligraphy Mindfulness increase Telomere Length in Peripheral Blood Leukocytes in adults?
  • Will this increase of Telomere Length in Peripheral Blood Leukocytes in adults be statistically significant? Researchers will compare the length of Telomere in peripheral blood Leukocytes at beginning of the mindfulness practices to the length of Telomere in peripheral blood Leukocytes at 3 months and at 9 months of regular daily practices. Participants will:
  • Receive a transmission of Subtle energy at beginning of practices
  • Visit the Laboratory for a blood sample taken at beginning, at 3 months and at 9 months of practices.
  • Fill the Study Questionnaires at beginning, at 3 months and at 9 months of practices.
  • Practice the Mindfulness with Tao Calligraphy daily 1 hour in the morning and 1 hour in the evening.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2025

Completed
Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

1.1 years

First QC Date

April 4, 2024

Last Update Submit

April 10, 2025

Conditions

Keywords

Telomere LengthLeukocytesMindfulnessCalligraphyQuality of LifeTao

Outcome Measures

Primary Outcomes (1)

  • Telomere Length in Peripheral blood leukocytes

    The Change of Telomere Length in Peripheral blood leukocytes after 9 months of Mindfulness Practice with Tao Calligraphy

    9 months

Secondary Outcomes (1)

  • Quality of Life by John Ware's SF-36 Quality of Life questionnaire (that produces eight scores with 0-to-100 scale, 100 being the best possible outcome).

    9 months

Study Arms (1)

SIMPLE FOLLOW UP GROUP

OTHER

Every subject who is accepted into the study, will receive prior to the inception of practice transmission of pure energy (blessing) and will be instructed on how to practice meditations with Tao Calligraphy. Blood samples will be drawn at DAP accredited institution in British Columbia (Life Labs or Vancouver Coastal Health) and will be promptly sent by currier to Repeat Diagnostics, All participants will have blood samples drawn and Questionnaire filled at the entry time point (Time 0), at the end of 3 months (Time 1), and at the end of 9 months (Time 2).

Other: Mindfulness practice with Calligraphy

Interventions

The unique style of Art Meditation where mindfulness (heightened awareness) is achieved by combination of movement and focus on Chinese Tao Calligraphy while chanting a mantra. The practitioners repeatedly trace the lines of Tao calligraphy with fingers and chant the mantra. This enables them to achieve deep concentration, while maintaining fully alert state. The practice can be done in sitting or standing, depending on the health status and age.

SIMPLE FOLLOW UP GROUP

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult subjects / patients (age 60 years and over) we expect at 60 years people have already measurable shortening of telomeres
  • Healthy or Ill, with the exception of genetic illnesses and cancer (for which treatments could negatively impact telomeres)
  • Willingness and ability to comply with data collection requirements.
  • Complete submission of required documentation prior to enrollment into the study, including informed consent and consent to release of information.
  • Willingness to allow their data to be used for research purposes and published as deemed fit (while conforming to all applicable privacy laws) by Sha Research Foundation.
  • Willingness to practice the daily calligraphy meditations and follow the protocol.

You may not qualify if:

  • Bipolar disorders, other serious mental disorders (e.g. schizophrenia, psychosis), genetic illnesses (primarily affected chromosomes), and cancer (treatment could negatively impact telomere during research period)
  • inability to sign consent and follow instructions
  • Unwillingness to participate in data gathering
  • Unable to follow the practice regimen, including the daily calligraphy meditations
  • Pregnant or nursing. Participants who become pregnant during the study will be required to end their participation. (to avoid any, at current time unknown, potential negative effect of the study on the fetus).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sha Research Foundation (Branch)

North Vancouver, British Columbia, V7R 1P5, Canada

Location

Related Publications (28)

  • Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, Zanesco AP, Aichele SR, Sahdra BK, MacLean KA, King BG, Shaver PR, Rosenberg EL, Ferrer E, Wallace BA, Saron CD. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology. 2011 Jun;36(5):664-81. doi: 10.1016/j.psyneuen.2010.09.010. Epub 2010 Oct 29.

    PMID: 21035949BACKGROUND
  • Dal Lin C, Marinova M, Brugnolo L, Rubino G, Plebani M, Iliceto S, Tona F. Rapid changes of miRNAs-20, -30, -410, -515, -134, and -183 and telomerase with psychological activity: A one year study on the relaxation response and epistemological considerations. J Tradit Complement Med. 2021 Feb 15;11(5):409-418. doi: 10.1016/j.jtcme.2021.02.005. eCollection 2021 Sep.

    PMID: 34522635BACKGROUND
  • Pavanello S, Campisi M, Tona F, Lin CD, Iliceto S. Exploring Epigenetic Age in Response to Intensive Relaxing Training: A Pilot Study to Slow Down Biological Age. Int J Environ Res Public Health. 2019 Aug 23;16(17):3074. doi: 10.3390/ijerph16173074.

    PMID: 31450859BACKGROUND
  • Thimmapuram J, Pargament R, Sibliss K, Grim R, Risques R, Toorens E. Effect of heartfulness meditation on burnout, emotional wellness, and telomere length in health care professionals. J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):21-27. doi: 10.1080/20009666.2016.1270806. eCollection 2017 Jan.

    PMID: 28634520BACKGROUND
  • Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. Correction: A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLoS Med. 2019 Feb 25;16(2):e1002760. doi: 10.1371/journal.pmed.1002760. eCollection 2019 Feb.

    PMID: 30802240BACKGROUND
  • Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLoS Med. 2018 Dec 31;15(12):e1002718. doi: 10.1371/journal.pmed.1002718. eCollection 2018 Dec.

    PMID: 30596641BACKGROUND
  • Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, Hou L, Baccarelli AA, Li Y, Stewart JD, Whitsel EA, Assimes TL, Ferrucci L, Horvath S. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019 Jan 21;11(2):303-327. doi: 10.18632/aging.101684.

    PMID: 30669119BACKGROUND
  • Field AE, Robertson NA, Wang T, Havas A, Ideker T, Adams PD. DNA Methylation Clocks in Aging: Categories, Causes, and Consequences. Mol Cell. 2018 Sep 20;71(6):882-895. doi: 10.1016/j.molcel.2018.08.008.

    PMID: 30241605BACKGROUND
  • Goldman EA, Eick GN, Compton D, Kowal P, Snodgrass JJ, Eisenberg DTA, Sterner KN. Evaluating minimally invasive sample collection methods for telomere length measurement. Am J Hum Biol. 2018 Jan;30(1):10.1002/ajhb.23062. doi: 10.1002/ajhb.23062. Epub 2017 Sep 26.

    PMID: 28949426BACKGROUND
  • Ahadi S, Zhou W, Schussler-Fiorenza Rose SM, Sailani MR, Contrepois K, Avina M, Ashland M, Brunet A, Snyder M. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat Med. 2020 Jan;26(1):83-90. doi: 10.1038/s41591-019-0719-5. Epub 2020 Jan 13.

    PMID: 31932806BACKGROUND
  • Gorenjak V, Akbar S, Stathopoulou MG, Visvikis-Siest S. The future of telomere length in personalized medicine. Front Biosci (Landmark Ed). 2018 Mar 1;23(9):1628-1654. doi: 10.2741/4664.

    PMID: 29293454BACKGROUND
  • Notterman DA, Schneper L. Telomere Time-Why We Should Treat Biological Age Cautiously. JAMA Netw Open. 2020 May 1;3(5):e204352. doi: 10.1001/jamanetworkopen.2020.4352. No abstract available.

    PMID: 32364591BACKGROUND
  • Koliada AK, Krasnenkov DS, Vaiserman AM. Telomeric aging: mitotic clock or stress indicator? Front Genet. 2015 Mar 16;6:82. doi: 10.3389/fgene.2015.00082. eCollection 2015. No abstract available.

    PMID: 25852738BACKGROUND
  • Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35(1):112-31. doi: 10.1093/epirev/mxs008. Epub 2013 Jan 9.

    PMID: 23302541BACKGROUND
  • Vaiserman A, Krasnienkov D. Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives. Front Genet. 2021 Jan 21;11:630186. doi: 10.3389/fgene.2020.630186. eCollection 2020.

    PMID: 33552142BACKGROUND
  • Skytthe A, Pedersen NL, Kaprio J, Stazi MA, Hjelmborg JV, Iachine I, Vaupel JW, Christensen K. Longevity studies in GenomEUtwin. Twin Res. 2003 Oct;6(5):448-54. doi: 10.1375/136905203770326457.

    PMID: 14624729BACKGROUND
  • Herskind AM, McGue M, Holm NV, Sorensen TI, Harvald B, Vaupel JW. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet. 1996 Mar;97(3):319-23. doi: 10.1007/BF02185763.

    PMID: 8786073BACKGROUND
  • vB Hjelmborg J, Iachine I, Skytthe A, Vaupel JW, McGue M, Koskenvuo M, Kaprio J, Pedersen NL, Christensen K. Genetic influence on human lifespan and longevity. Hum Genet. 2006 Apr;119(3):312-21. doi: 10.1007/s00439-006-0144-y. Epub 2006 Feb 4.

    PMID: 16463022BACKGROUND
  • Boyce WT, Sokolowski MB, Robinson GE. Genes and environments, development and time. Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23235-23241. doi: 10.1073/pnas.2016710117.

    PMID: 32967067BACKGROUND
  • Steenman M, Lande G. Cardiac aging and heart disease in humans. Biophys Rev. 2017 Apr;9(2):131-137. doi: 10.1007/s12551-017-0255-9. Epub 2017 Mar 20.

    PMID: 28510085BACKGROUND
  • Kalyani RR, Egan JM. Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am. 2013 Jun;42(2):333-47. doi: 10.1016/j.ecl.2013.02.010. Epub 2013 Mar 22.

    PMID: 23702405BACKGROUND
  • Aunan JR, Cho WC, Soreide K. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks. Aging Dis. 2017 Oct 1;8(5):628-642. doi: 10.14336/AD.2017.0103. eCollection 2017 Oct.

    PMID: 28966806BACKGROUND
  • Kao H Sr, Zhu L, Chao AA, Chen HY, Liu IC, Zhang M. Calligraphy and meditation for stress reduction: an experimental comparison. Psychol Res Behav Manag. 2014 Feb 13;7:47-52. doi: 10.2147/PRBM.S55743. eCollection 2014.

    PMID: 24611024BACKGROUND
  • Kao HS, Lam SP, Kao TT. Chinese calligraphy handwriting (CCH): a case of rehabilitative awakening of a coma patient after stroke. Neuropsychiatr Dis Treat. 2018 Jan 31;14:407-417. doi: 10.2147/NDT.S147753. eCollection 2018.

    PMID: 29440902BACKGROUND
  • Zhu Z, Wang R, Kao HS, Zong Y, Liu Z, Tang S, Xu M, Liu IC, Lam SP. Effect of calligraphy training on hyperarousal symptoms for childhood survivors of the 2008 China earthquakes. Neuropsychiatr Dis Treat. 2014 Jun 3;10:977-85. doi: 10.2147/NDT.S55016. eCollection 2014.

    PMID: 24940061BACKGROUND
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

    PMID: 1593914BACKGROUND
  • Ware JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. doi: 10.1097/00007632-200012150-00008. No abstract available.

    PMID: 11124729BACKGROUND
  • Baerlocher GM, Lansdorp PM. Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH. Cytometry A. 2003 Sep;55(1):1-6. doi: 10.1002/cyto.a.10064.

    PMID: 12938182BACKGROUND

MeSH Terms

Conditions

Thromboangiitis Obliterans

Condition Hierarchy (Ancestors)

Arterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesVasculitis

Study Officials

  • Peter Hudoba De Badyn, MD, FRCS

    Sha Research Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The study will be performed as a Pilot follow-up study, should the 0 Hypothesis be successfully rejected, this study will be followed by a formal Double Blind Randomized Crossover Study. We plan subjects may enter the study as a group and will have measurements done within short time frame from each other at beginning and at the end of 3 and 9 months. As this is a pilot study, there will be no randomization into treatment and control group, as a control we will use the "Normal" values of telomere from general population. All subjects will receive a transmission and then will be practicing Tao Calligraphy mindfulness daily during the 9 months. Every subject who is accepted into the study, will have blood sample taken for analysis and will fill Rand SF 36 Questionnaire. Afterwards, will receive transmission of subtle energy by Zhi Gang Sha (or his designee) and will be instructed on how to practice mindfulness with Tao Calligraphy.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Research at Sha Research Foundation

Study Record Dates

First Submitted

April 4, 2024

First Posted

April 10, 2024

Study Start

June 15, 2023

Primary Completion

July 31, 2024

Study Completion

March 25, 2025

Last Updated

April 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Will need to contact IRB if permitted, as this is not in approved protocol

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
September 2024 to March 2025
Access Criteria
Anyone on Clinical Trials Gov

Available IPD Datasets

Study Protocol (Pro00071128)Access

Locations